Brief: Aurobindo Pharma Q3 Consol Net PAT 9.1 Billion Rupees
09/02/2026 15:06
Feb 9 (Reuters) - Aurobindo Pharma Ltd ARBN.NS: AUROBINDO PHARMA Q3 CONSOL NET PAT 9.1 BILLION RUPEES AUROBINDO PHARMA Q3 CONSOL TOTAL REVENUE FROM OPERATIONS 86.46 BILLION RUPEES Source text: ID:nNSE3S9nzx Further company coverage: ARBN.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11